HilleVax (HLVX)
(Delayed Data from NSDQ)
$12.99 USD
-0.09 (-0.69%)
Updated Apr 23, 2024 09:30 AM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HLVX 12.99 -0.09(-0.69%)
Will HLVX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HLVX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HLVX
Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade
HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade
HLVX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does HilleVax, Inc. (HLVX) Have the Potential to Rally 107.23% as Wall Street Analysts Expect?
Wall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should Know
How Much Upside is Left in HilleVax, Inc. (HLVX)? Wall Street Analysts Think 87.76%
Other News for HLVX
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)
HLVX Crosses Below Key Moving Average Level
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), HilleVax, Inc (HLVX) and Cabaletta Bio (CABA)
HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)